160 related articles for article (PubMed ID: 38379304)
41. Retrotransposition and cell-to-cell transfer of foamy viruses.
Heinkelein M; Rammling M; Juretzek T; Lindemann D; Rethwilm A
J Virol; 2003 Nov; 77(21):11855-8. PubMed ID: 14557671
[TBL] [Abstract][Full Text] [Related]
42. Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element.
Wang L; Wang Z; Zhang F; Zhu R; Bi J; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
Int J Med Sci; 2016; 13(4):286-91. PubMed ID: 27076785
[TBL] [Abstract][Full Text] [Related]
43. Increased utility in the CNS of a powerful neuron-specific tetracycline-regulatable adenoviral system developed using a post-transcriptional enhancer.
Lee YB; Cosgrave AS; Glover CP; Bienemann A; Heywood D; Hobson RJ; Uney JB
J Gene Med; 2005 May; 7(5):576-83. PubMed ID: 15580589
[TBL] [Abstract][Full Text] [Related]
44. Characterization of Prototype Foamy Virus Infectivity in Transportin 3 Knockdown Human 293t Cell Line.
Hamid FB; Kim J; Shin CG
J Microbiol Biotechnol; 2017 Feb; 27(2):380-387. PubMed ID: 27840397
[TBL] [Abstract][Full Text] [Related]
45. N-Myc interactor inhibits prototype foamy virus by sequestering viral Tas protein in the cytoplasm.
Hu X; Yang W; Liu R; Geng Y; Qiao W; Tan J
J Virol; 2014 Jun; 88(12):7036-44. PubMed ID: 24719420
[TBL] [Abstract][Full Text] [Related]
46. Production of foamy virus vector and transduction of hematopoietic cells.
Josephson NC; Russell DW
Cold Spring Harb Protoc; 2010 Sep; 2010(9):pdb.prot5481. PubMed ID: 20810629
[TBL] [Abstract][Full Text] [Related]
47. Lentivirus vector driven by polybiquitin C promoter without woodchuck posttranscriptional regulatory element and central polypurine tract generates low level and short-lived reporter gene expression.
Ngai SC; Rosli R; Nordin N; Veerakumarasivam A; Abdullah S
Gene; 2012 May; 498(2):231-6. PubMed ID: 22366305
[TBL] [Abstract][Full Text] [Related]
48. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
Werner M; Kraunus J; Baum C; Brocker T
Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
[TBL] [Abstract][Full Text] [Related]
49. Foamy virus for efficient gene transfer in regeneration studies.
Khattak S; Sandoval-Guzmán T; Stanke N; Protze S; Tanaka EM; Lindemann D
BMC Dev Biol; 2013 May; 13():17. PubMed ID: 23641815
[TBL] [Abstract][Full Text] [Related]
50. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
[TBL] [Abstract][Full Text] [Related]
51. Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles.
Stirnnagel K; Lüftenegger D; Stange A; Swiersy A; Müllers E; Reh J; Stanke N; Grosse A; Chiantia S; Keller H; Schwille P; Hanenberg H; Zentgraf H; Lindemann D
Retrovirology; 2010 May; 7():45. PubMed ID: 20478027
[TBL] [Abstract][Full Text] [Related]
52. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
Gene; 2006 May; 372():153-61. PubMed ID: 16488559
[TBL] [Abstract][Full Text] [Related]
53. Evidence for the in vivo safety of insulated foamy viral vectors.
Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
[TBL] [Abstract][Full Text] [Related]
54. Foamy virus--adenovirus hybrid vectors.
Picard-Maureau M; Kreppel F; Lindemann D; Juretzek T; Herchenröder O; Rethwilm A; Kochanek S; Heinkelein M
Gene Ther; 2004 Apr; 11(8):722-8. PubMed ID: 14724670
[TBL] [Abstract][Full Text] [Related]
55. [Comparison of several viral vectors for gene therapy of corneal endothelial cells].
Beutelspacher SC; Serbecic N; Tan P; McClure MO
Ophthalmologe; 2005 Dec; 102(12):1168-74. PubMed ID: 15886987
[TBL] [Abstract][Full Text] [Related]
56. A foamy virus vector system for stable and efficient RNAi expression in mammalian cells.
Papadaki M; Siapati EK; Vassilopoulos G
Hum Gene Ther; 2011 Oct; 22(10):1293-303. PubMed ID: 21456885
[TBL] [Abstract][Full Text] [Related]
57. Antiviral role of IFITM3 in prototype foamy virus infection.
Wang Z; Tuo X; Zhang J; Chai K; Tan J; Qiao W
Virol J; 2022 Nov; 19(1):195. PubMed ID: 36419065
[TBL] [Abstract][Full Text] [Related]
58. Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.
Uchiyama T; Adriani M; Jagadeesh GJ; Paine A; Candotti F
Mol Ther; 2012 Jun; 20(6):1270-9. PubMed ID: 22215016
[TBL] [Abstract][Full Text] [Related]
59. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
[TBL] [Abstract][Full Text] [Related]
60. Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression.
Rothenaigner I; Kramer S; Meggendorfer M; Rethwilm A; Brack-Werner R
Gene Ther; 2009 Mar; 16(3):349-58. PubMed ID: 19052634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
